Live feed08:30:00·80dPRReleasevia QuantisnowQuoin Pharmaceuticals Provides Clinical and Regulatory Update from Constructive Type C Meeting with U.S. FDA for QRX003 in Netherton SyndromeByQuantisnow·Wall Street's wire, on your screen.QNRX· Quoin Pharmaceuticals Ltd.Health Care
